Literature DB >> 18952489

Genetic differences between primary larynx and pharynx carcinomas and their matched lymph node metastases by multiplex ligation-dependent probe amplification.

Marta Alonso Guervós1, César Alvarez Marcos, José Luis Llorente, Andrés Sampedro Nuño, Carlos Suárez, Mario Hermsen.   

Abstract

Lymph nodes metastasis is a major risk factor related to poor survival in larynx and pharynx carcinomas. The aim of this study is to search for markers of lymph node involvement analyzing the genetic differences between primary larynx and pharynx squamous cell carcinomas and their corresponding lymph node metastases. Twenty-five primary tumors and their corresponding lymph node metastases were examined. DNA copy number changes of 37 genes were analyzed by multiplex ligation-dependent probe amplification (MLPA). Loss of CDKN2A (9p21) occurred in 14 out of 25 pairs (56%) of primary tumor and lymph node metastases. Loss of LMNA (1q21) was exclusively detected in 8 lymph node samples (32%). Loss of CTNNB1 (3p22) and gain of CDKN2D (19p13) were also significantly more frequent in lymph node metastases. Other aberrations related to lymph node metastases were loss of MFHAS1 (8p23), RECQL4 (8q24) and gain of N33 (8p22) and TP53 (17p13). Primary tumor and corresponding lymph node metastases showed common genetic changes. However, the lymph node metastases presented with a number of additional alterations. Acquisition of these alterations may play a role in lymphatic metastasis development.

Entities:  

Mesh:

Year:  2008        PMID: 18952489     DOI: 10.1016/j.oraloncology.2008.08.005

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  6 in total

1.  EGFR status and KRAS/BRAF mutations in intestinal-type sinonasal adenocarcinomas.

Authors:  Cristina García-Inclán; Fernando López; Jhudit Pérez-Escuredo; Mari Paz Cuesta-Albalad; Blanca Vivanco; Irene Centeno; Milagros Balbín; Carlos Suárez; José Luis Llorente; Mario A Hermsen
Journal:  Cell Oncol (Dordr)       Date:  2012-10-11       Impact factor: 6.730

2.  MASL1 induces erythroid differentiation in human erythropoietin-dependent CD34+ cells through the Raf/MEK/ERK pathway.

Authors:  Chutima Kumkhaek; Wulin Aerbajinai; Wenli Liu; Jianqiong Zhu; Naoya Uchida; Roger Kurlander; Matthew M Hsieh; John F Tisdale; Griffin P Rodgers
Journal:  Blood       Date:  2013-01-17       Impact factor: 22.113

3.  Biological resonance for cancer metastasis, a new hypothesis based on comparisons between primary cancers and metastases.

Authors:  Dongwei Gao; Sha Li
Journal:  Cancer Microenviron       Date:  2013-11-10

Review 4.  Use of the MLPA assay in the molecular diagnosis of gene copy number alterations in human genetic diseases.

Authors:  Liborio Stuppia; Ivana Antonucci; Giandomenico Palka; Valentina Gatta
Journal:  Int J Mol Sci       Date:  2012-03-08       Impact factor: 6.208

5.  Genomic alterations on 8p21-p23 are the most frequent genetic events in stage I squamous cell carcinoma of the lung.

Authors:  Jiun Kang
Journal:  Exp Ther Med       Date:  2014-12-09       Impact factor: 2.447

6.  The Babesia bovis hap2 gene is not required for blood stage replication, but expressed upon in vitro sexual stage induction.

Authors:  Hala E Hussein; Reginaldo G Bastos; David A Schneider; Wendell C Johnson; Fatma K Adham; William C Davis; Jacob M Laughery; David R Herndon; Heba F Alzan; Massaro W Ueti; Carlos E Suarez
Journal:  PLoS Negl Trop Dis       Date:  2017-10-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.